AFP and hepatocellular carcinoma: Hameed et al. 2014 established that by implementing a cutoff of patients with preoperative AFP > 1000 ng/mL they would exclude only 4.7% of patients from being eligible for transplant, while gaining a 20% reduction in post transplantation HCC recurrence [14].